I agree that this site is using cookies. You can find further informations here.
X
Okubo, Yukari
186  results:
Search for persons X
?
1

Exploratory Efficacy Evaluation of Apremilast for the Treat..:

Okubo, Yukari ; Terui, Tadashi ; Kobayashi, Satomi...
Dermatology and Therapy.  14 (2024)  7 - p. 1863-1873 , 2024
Link: https://doi.org/10.1007/..
 
?
2

Safety and effectiveness of apremilast in Japanese patients..:

Ohtsuki, Mamitaro ; Okubo, Yukari ; Saeki, Hidehisa...
The Journal of Dermatology.  51 (2024)  7 - p. 950-963 , 2024
Link: https://doi.org/10.1111/..
 
?
3

Paediatric pustulotic arthro‐osteitis patient with an IL36R..:

Takami, Kenji ; Tsuji, Shigeyoshi ; Jokoji, Ryu..
Experimental Dermatology.  33 (2024)  1 - p. , 2024
Link: https://doi.org/10.1111/..
 
?
4

Bimekizumab 3-year Safety and Tolerability in Moderate to S..:

Lebwohl, Mark ; Strober, Bruce ; Langley, Richard G....
SKIN The Journal of Cutaneous Medicine.  8 (2024)  1 - p. s305 , 2024
Link: https://doi.org/10.25251..
 
?
5

Orofacial granulomatosis associated with indium allergy and..:

Yoshida, Kaoruko ; Numata, Takafumi ; Sugisaki, Risa...
The Journal of Dermatology.  , 2024
Link: https://doi.org/10.1111/..
 
?
6

Consistent Efficacy of Apremilast in Patients with Psoriasi..:

Abe, Masatoshi ; Okubo, Yukari ; Takahashi, Hidetoshi...
Dermatology and Therapy.  14 (2024)  6 - p. 1587-1597 , 2024
Link: https://doi.org/10.1007/..
 
?
7

A case of anaphylaxis after ingestion of Enokitake (Flammul..:

Minami, Yoshihito ; Kanzaki, Mirei ; Egusa, Chizu...
The Journal of Dermatology.  , 2024
Link: https://doi.org/10.1111/..
 
?
8

Deucravacitinib, an oral, selective, allosteric tyrosine ki..:

Imafuku, Shinichi ; Okubo, Yukari ; Tada, Yayoi...
The Journal of Dermatology.  51 (2024)  3 - p. 365-379 , 2024
Link: https://doi.org/10.1111/..
 
?
9

Efficacy and Safety of Brodalumab, an Anti-interleukin-17 R..:

Okubo, Yukari ; Kobayashi, Satomi ; Murakami, Masamoto...
American Journal of Clinical Dermatology.  , 2024
Link: https://doi.org/10.1007/..
 
?
10

Bimekizumab safety in patients with moderate-to-severe plaq..:

Gordon, Kenneth B ; Langley, Richard G ; Warren, Richard B...
British Journal of Dermatology.  190 (2023)  4 - p. 477-485 , 2023
Link: https://doi.org/10.1093/..
 
?
11

43754 Efficacy and safety of spesolimab for the treatment o..:

Warren, Richard B. ; Okubo, Yukari ; Anadkat, Milan...
Journal of the American Academy of Dermatology.  89 (2023)  3 - p. AB42 , 2023
Link: https://doi.org/10.1016/..
 
?
12

English version of Japanese guidance for the use of oral Ja..:

Saeki, Hidehisa ; Mabuchi, Tomotaka ; Asahina, Akihiko...
The Journal of Dermatology.  50 (2023)  5 - p. , 2023
Link: https://doi.org/10.1111/..
 
?
13

43110 Deucravacitinib, a Selective Tyrosine Kinase 2 Inhibi..:

Tada, Yayoi ; Imafuku, Shinichi ; Okubo, Yukari...
Journal of the American Academy of Dermatology.  89 (2023)  3 - p. AB147 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Treatment patterns of systemic drug use in Japanese patient..:

Tada, Yayoi ; Komine, Mayumi ; Okubo, Yukari...
The Journal of Dermatology.  51 (2023)  2 - p. 210-222 , 2023
Link: https://doi.org/10.1111/..
 
?
15

Real‐world retention rates and effectiveness of secukinumab..:

Tada, Yayoi ; Morita, Akimichi ; Yamanaka, Keiichi...
The Journal of Dermatology.  50 (2023)  11 - p. 1415-1426 , 2023
Link: https://doi.org/10.1111/..
 
1-15